PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Valtech Cardio Ltd.

USPTO PatentsView assignee record — 78 granted patents across 4 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Explore the portfolio See the ranking
78
Total patents granted
4
CPC technology areas
21.0
Avg claims per patent
-41%
5-year filing velocity

The verdict

Valtech holds 78 US patents across 4 technology areas — rank #4,540 of 50,000 tracked assignees.

#4,540
of 50,000 US assignees by volume
Top 49%
by Innovation Score (35.7/100)
21.0
avg claims per patent
-41%
filing velocity, last 5 yrs

Portfolio overview

Valtech Cardio Ltd. has been granted 78 US utility patents between 2015 and 2022, placing Valtech Cardio Ltd. at rank #4,540 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.0 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Valtech Cardio Ltd. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 35.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 29 grants, compared with 49 in the 2015–2019 window — a -41% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Valtech Cardio Ltd.'s 21.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Valtech Cardio Ltd. against peers pursuing similar technology classes.

How does Valtech compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Valtech holds 78 patents — placing it at rank #4,540 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Valtech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

46810121416 20152016201720182019202020212022 5
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Valtech Cardio Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 11 14.1%
2016 6 7.7%
2017 10 12.8%
2018 9 11.5%
2019 13 16.7%
2020 10 12.8%
2021 14 17.9%
2022 5 6.4%

Which technologies does Valtech Cardio Ltd. patent most?

Top 4 of 4 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#4,540

Across all tracked assignees

Innovation Score

35.7 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Valtech Cardio Ltd. hold?
Valtech Cardio Ltd. holds 78 US granted patents filed between 2015 and 2022, spanning 4 technology areas.
What is Valtech Cardio Ltd.'s Innovation Score?
Valtech Cardio Ltd. has an Innovation Score of 35.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Valtech Cardio Ltd. focus on?
Valtech Cardio Ltd.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 73 patents. The company has filed patents in 4 CPC subclasses total.
Is Valtech Cardio Ltd.'s patent filing rate increasing or decreasing?
Valtech Cardio Ltd.'s recent filing velocity is -41% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Valtech Cardio Ltd.'s patents?
Valtech Cardio Ltd.'s patents average 21.0 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Valtech Cardio Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

Valtech's 78 grants land it in the top 49% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Valtech ranks #4,540 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61F — see who else leads that technology area. A61F leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

A61F technology

Valtech Cardio Ltd.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where Valtech Cardio Ltd. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov